Compare Nuwellis Inc (NUWE) vs Ferrari NV (RACE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Ferrari NV — how do they compare? Nuwellis Inc trades at $0.8 (market cap $2.54M), while Ferrari NV trades at $409.61 (market cap $70.66B). The key difference: Ferrari NV is far larger — about 27818.9× Nuwellis Inc's market cap, and Ferrari NV pays a 1.05% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| NUWE | RACE | |
|---|---|---|
Market Cap | $2.54M | $70.66B |
Sector | Technology | Consumer Cyclical |
52-Week High | $164.50 | $504.09 |
52-Week Low | $0.73 | $314.63 |
Enterprise Value | -$1.17M | $72.61B |
Dividend Yield | — | 1.05% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.7878, up 0.88% today, but remains in a bearish technical trend. The company shows strong gross margins of 69.69% and double-digit revenue growth, but faces significant profitability challenges with negative net income margins and ROE. Recent developments include a reverse stock split, new CEO appointment, and strategic partnerships expanding pediatric care footprint.
While NUWE demonstrates operational progress with revenue growth and margin improvement, persistent losses and negative cash flow present substantial risk. The mixed analyst sentiment and bearish technical indicators suggest cautious approach. Investment appeal hinges on successful execution of financial efficiency strategy and path to profitability.
Ferrari (RACE) trades at $405.94, down 0.98% on the day, amid a bearish technical signal. The stock shows strong fundamentals with consistent earnings beats, revenue growth from $5.1B in 2022 to $7.1B in 2025, and robust profitability margins. Recent news highlights a record $40 million auction of its first electric car, reinforcing brand prestige. Analyst consensus is bullish with a $462.67 price target, though technical indicators suggest near-term pressure with support at $402 and resistance at $411.
The outlook remains positive due to Ferrari's pricing power and margin strength, but risks include high valuation multiples and economic sensitivity. Institutional buying and share repurchases provide support, yet investors face volatility from technical bearishness and competitive pressures in the luxury auto sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Ferrari NV
Ferrari engineers and manufactures some of the world's most expensive exotic sports cars. The Ferrari brand is synonymous with Formula One racing, exclusivity, Italian design, and state-of-the-art technology. Ferrari also has a captive finance company that provides funding for dealers and clients.
Read more on RACE →
